NeuroPace, Inc. (NASDAQ:NPCE) Just Reported Third-Quarter Earnings: Have Analysts Changed Their Mind On The Stock? [Yahoo! Finance]
Neuropace, Inc. (NPCE)
Company Research
Source: Yahoo! Finance
The results overall were pretty good, with revenues of US$27m exceeding expectations and statutory losses coming in at justUS$0.11 per share, some 44% below what the analysts had forecast. This is an important time for investors, as they can track a company's performance in its report, look at what experts are forecasting for next year, and see if there has been any change to expectations for the business. So we collected the latest post-earnings statutory consensus estimates to see what could be in store for next year. Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit. NasdaqGM:NPCE Earnings and Revenue Growth November 8th 2025 Taking into account the latest results, the consensus forecast from NeuroPace's eight analysts is for revenues of US$99.0m in 2026. This reflects a modest 4.4% improvement in revenue compared to the last 12 months. Losses are expected to be contained, narrowing 15% from last year to US
Show less
Read more
Impact Snapshot
Event Time:
NPCE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NPCE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NPCE alerts
High impacting Neuropace, Inc. news events
Weekly update
A roundup of the hottest topics
NPCE
News
- NeuroPace to Highlight Life-Changing Outcomes and AI-Powered Confident Care at the 2025 American Epilepsy Society (AES) Annual Meeting [Yahoo! Finance]Yahoo! Finance
- NeuroPace to Highlight Life-Changing Outcomes and AI-Powered Confident Care at the 2025 American Epilepsy Society (AES) Annual MeetingBusiness Wire
- NeuroPace Announces Favorable Medicare Reimbursement Increases for RNS System Physician and Hospital Outpatient ServicesBusiness Wire
- NeuroPace (NPCE) Q3 2025 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- NeuroPace (NPCE): High Growth Forecast and Path to Profitability Reinforce Bullish Narratives [Yahoo! Finance]Yahoo! Finance
NPCE
Earnings
- 11/4/25 - Beat
NPCE
Sec Filings
- 12/4/25 - Form 4
- 12/1/25 - Form 4
- 12/1/25 - Form 4
- NPCE's page on the SEC website